Ozair Rahman1, Carmen Blanken2, Pallavi P Balte3, Bharath Ambale Venkatesh4, Martin Prince5, David A Bluemke6, Oliver Wieben7, Joao Lima8, Stephen M Dashnaw9, James Carr2, Graham G Barr3, and Michael Markl2
1Department of Radiology, Northwestern University, Chicago, IL, United States, 2Radiology, Northwestern University, Chicago, IL, United States, 3Epidemiology, Columbia University, New York, NY, United States, 4John's Hopkins, Baltimore, MD, United States, 5Radiology, Cornell, New York, NY, United States, 6Radiology and Imaging Sciences, National Institutes of Health, Bathesda, MD, United States, 7Radiology, University of Wisconson-Madison, Madison, WI, United States, 8Radiology, John's Hopkins, Baltimore, MD, United States, 9Radiology, Columbia University, New York, NY, United States
Synopsis
Chronic Obstructive Pulmonary Disease is the third leading
cause of death in the United States, and affects 24 million Americans with over
65 million people affected world-wide. Up-to 58% of patients develop exertional
pulmonary hypertension and right ventricular volume changes. Understanding this
phenomenon, known as cor pulmonale can help us gain insight into the complex
pathophysiology involved. This pilot study attempts to apply 4D flow MRI in
patients with varying degrees of COPD, and assess the feasibility,
reproducibility and accuracy of this technique.
Purpose:
Chronic Obstructive Pulmonary
Disease (COPD) is associated with hemodynamic changes in the pulmonary
vasculature, potentially resulting in cor
pulmonale or right ventricular (RV) hypertrophy, and hyperinflation,
potentially leading to underfilling of the RV and cor pulmonale parvis1. 4D flow MRI offers accurate quantification of
flow parameters including net flow, peak velocity, and complex flow hemodynamic
visualization in the arterial circulation2,3. The ability to retrospectively
analyze patients with 4D flow MRI also offers added benefit. This pilot study
attempts to assess the feasibility and reproducibility of 4D flow MRI in its
application to the great veins and right heart in COPD.Methods:
Measurements were performed in the multicenter MESA COPD
Study, a nested case-control study of older smokers with COPD and controls. Participants
were scanned with 3D time-resolved (cine) radiofrequency spoiled phase-contrast
gradient-echo sequence with three-directional velocity encoding (4D flow MRI)
at 1.5T Magnetic Resonance (MR) scanner (Siemens Magnetom Aera, Erlangen,
Germany). The 4D flow MRIs were read by two observers in 10 patients with COPD
and 10 aged matched controls who were blinded to clinical status of the
patient. Volumetric coverage included the superior vena cava, inferior vena
cava, right atrium, right ventricle, main pulmonary artery, right and left
pulmonary arterial branches, and pulmonary veins. Net flow, peak velocity, and
retrograde fraction were calculated at each respective area. All data are
presented as mean ±
SD. Inter-observer and intra-observer reliability were assessed by
comparing the net flow metrics generated by two independent observers and by the
same observer on two occasions, respectively. Intra-class correlation (ICC) coefficients
for both inter- and intra-observer reliability were calculated using one-way
ANOVA with random effects in entire sample and also separately in cases and
controls. Bland-Altman analysis was also used to quantify agreement between the
two observers for net flow through pulmonary veins and arteries by studying the
mean difference and limits of agreement. Results:
Of study subjects, 55% were men, 55% were white, 34% were African
Americans and 16% were current smokers.
The mean age was 66.7 ± 6.5 years. The average ICC for intra- observer reliability
in entire sample was 0.93, ranging from a low of 0.67 (IVC below the diaphragm)
to a high of 0.98 (IVC above the diaphragm). The average ICC for inter- observer
reliability was 0.92, ranging from a low of 0.72 (IVC below the diaphragm) to a
high of 0.98 (Left PA and Left superior pulmonary vein) (Table 1). Subjects
with COPD and control subjects had similar ICC values. Bland-Altman graphs of
the arterial and venous results showed good agreement between observers (Figures
1, 2). The flow rates were consistent in
the main pulmonary artery (79 mL/cycle ± 20.5), in the left and right
pulmonary arteries (summed: 77.2mL/Cycle ± 12.7), across the Tricuspid valve (80.04 mL/cycle ±
28.93), in the superior and inferior vena cava (summed: 81.71 mL/cycle ± 22.81), and the pulmonary
veins (summed: 84.9
mL/cycle ± 42.49)
illustrating the conservation of flow (Table 1). There were no statistical differences
in net flow metrics between cases and controls in this small sample.Discussion
The results of this study demonstrate the feasibility and
reproducibility of measuring venous and right-sided arterial net flow using 4D
flow MRI in patients with COPD. The consistency of flow quantification and high
intra- and inter-observer correlation coefficient indicate reliable and
reproducible measurements. While 4D flow MRI still requires longer processing
and acquisition time, the potential complex flow visualization in patients with
this pulmonary disease could further the understanding of this disease process
(Figure 3). Conclusion
In conclusion, 4D flow MRI acquisition in COPD patients is a
promising means of measuring net flow through the thoracic vasculature. The
similar results and low variability values lends credence to this method, and
potential future clinical applications.
Acknowledgements
Funding NIH/NHLBI R01-HL093081, R01-HL077612References
[1] Hueper K, Vogel-Claussen J, Parikh MA,
et al. Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary
Disease and Emphysema. The MESA COPD Study. Am J Respir Crit Care Med
2015;192(5):570-80.
[2] Markl M, Carr
M, Ng J, et al. Assessment of left and right atrial 3D hemodynamics in patients
with atrial fibrillation: a 4D flow MRI study. Int J Cardiovasc Imaging
2016;32(5):807-15.
[3] von
Spiczak J, Crelier G, Giese D, Kozerke S, Maintz D, Bunck AC. Quantitative Analysis of Vortical
Blood Flow in the Thoracic Aorta Using 4D Phase Contrast MRI. PLoS One
2015;10(9):e0139025.